What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
Related Articles
-
AstraZeneca Makes Big U-Turn, Admits Covishield Can Cause Rare Side Effects
story that concerns all of us who have taken the anti covid vaccine Covid Shield, that was manufactured by the Serum Institute of India. It is originally an AstraZeneca vaccine. Our UK pharmaceutical giant AstraZeneca, that has that has actually formulated this vaccine has now acknowledged that its COVID-19 vaccine can in fact lead to a rare side effect. Should we be worried? Parmar has the details. AstraZeneca has admitted that its COVID-19 vaccine could cause a rare but deadly blood clotting...
-
AstraZeneca admits in court that its 'Covid vaccine can cause TTS side effects in rare cases'
NEW DELHI: UK Pharmaceutical company AstraZeneca has admitted that its Covid-19 vaccine has the potential to cause to a rare side effect called Thrombosis with Thrombocytopenia Syndrome (TTS), as reported by The Telegraph.AstraZeneca which collaborated with the University of Oxford to create the vaccine is currently dealing with a lawsuit that claims their vaccine has caused deaths and severe harm to those who received it.Previous year, Jamie Scott, a father of two, took legal action after...
-
AstraZeneca admits its Covid vaccine 'can cause TTS in very rare cases'. All you need to know | Mint
Pharmaceutical giant AstraZeneca has admitted that its Covid-19 vaccine can cause a rare side effect known as Thrombosis with Thrombocytopenia Syndrome' (TTS), according to a report by the London-based newspaper The Telegraph. The admission was made in court documents for the first time since rolling out of the vaccine.The pharmaceutical company, which developed the vaccine in partnership with the University of Oxford, is facing a class-action lawsuit alleging that their vaccine has resulted in...